|
|
Volumn 7, Issue 1, 2003, Pages 261-287
|
|
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HEMOPOIETIC GROWTH FACTOR;
INTERFERON;
MACROGOL;
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
PEGINTERFERON PLUS RIBAVIRIN;
RIBAVIRIN;
SEROTONIN UPTAKE INHIBITOR;
UNCLASSIFIED DRUG;
VIRUS RNA;
ALCOHOLISM;
AMINOTRANSFERASE BLOOD LEVEL;
CANCER RISK;
CHILDHOOD DISEASE;
CHRONIC HEPATITIS;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CYTOPENIA;
DEPRESSION;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG MIXTURE;
DRUG RESPONSE;
ELECTROIMMUNOASSAY;
FLU LIKE SYNDROME;
GENOTYPE;
HEALTH CARE ORGANIZATION;
HEMATOLOGIC DISEASE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RATE;
INTRAVENOUS DRUG ABUSE;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MENTAL DISEASE;
NEUROLOGIC DISEASE;
OCCUPATIONAL EXPOSURE;
PATIENT COMPLIANCE;
PATIENT SELECTION;
RECURRENT DISEASE;
REVIEW;
SEXUALLY TRANSMITTED DISEASE;
TREATMENT PLANNING;
UNITED STATES;
VIRUS LOAD;
VIRUS TRANSMISSION;
ANTIVIRAL AGENTS;
BLOOD TRANSFUSION;
CONSENSUS DEVELOPMENT CONFERENCES, NIH;
HEPATITIS C;
HUMANS;
SUBSTANCE ABUSE, INTRAVENOUS;
UNITED STATES;
|
|
EID: 0037301031
PISSN: 10893261
EISSN: None
Source Type: Journal
DOI: 10.1016/S1089-3261(02)00078-8 Document Type: Review |
|
Times cited : (167)
|
|
References (0)
|
